sellas life sciences share price

Is a late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. Chart represents SELLAS Life Sciences Group Inc.


Sls Short Interest Sellas Life Sciences Group Inc Stock Short Squeeze Short Sale Volume Borrow Rates Fails To Deliver

Try a valid symbol or a specific company name for.

. SLS SELLAS Life Sciences Group Inc Stock Price and Discussion Stocktwits. As of last trade Sellas Life Sciences Group Inc RXK3HAM traded at 268 452 above its 52-week low of 257 set on May 02 2022. NEW YORK March 31 2022 GLOBE NEWSWIRE -- SELLAS Life.

Shares in Sellas Life Sciences last closed at 272 and the price had moved by -6604 over the past 365 days. Get Sellas Life Sciences Group Inc SLSNASDAQ real-time stock quotes news price and financial information from CNBC. NEW YORK May 12 2022 GLOBE NEWSWIRE -- SELLAS Life Sciences Group Inc.

Price and volume over 1Y period. Sellas Life Sciences Group Inc. 4 brokers have issued 12-month price objectives for SELLAS Life Sciences Groups stock.

On November 28 2006 we changed our name to RXi Pharmaceuticals Corporation and began operations January 2007. NEW YORK May 12 2022 GLOBE NEWSWIRE -- SELLAS Life Sciences Group Inc. Get the latest SELLAS Life Sciences Group stock price and detailed information including SLS news historical charts and realtime prices.

Free Cash Flow per Share - - - - - Book Value per. 52 Week Range 32200 - 150789. The average twelve-month price target for SELLAS Life Sciences Group is 1788 with a high price target of 2100 and a low price target of 1600.

SLS stock price news historical charts analyst ratings and financial information from WSJ. According to the issued ratings of 4 analysts in the last year the consensus rating for SELLAS Life Sciences Group stock is Buy based on the current 4 buy ratings for SLS. View the latest SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Announces Pricing of 250 Million Underwritten Public Offering. Common Stock SLS Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. Day Range 33500 - 34700.

SLS SELLAS or the Company a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications today reported its financial results for the quarter ended March 31 2022 and. SELLAS Life Sciences Group Inc NASDAQ Updated Apr 27 2022 1135 PM. Summary of all time highs changes and price drops for SELLAS Life Sciences Group.

SLSNAQ price moved over -232 to 295 Apr 25 2022 Key statistics On Friday Sellas Life Sciences Group Inc SLSNAQ closed at 272 543 above its 52-week low of 258 set on Apr 28 2022. SLS NasdaqCM - NasdaqCM Real Time Price. Net loss was 167 million for the first quarter of 2022 or a basic and diluted loss per share of 105 as compared to a net loss of.

The Companys lead product candidate galinpepimut-S GPS is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center that. The chart has 1 X axis displaying Time. SELLAS Life Sciences Group NASDAQSLS adds US28m to market cap in the past 7 days.

May 13 80000 PM GMT-4 USD NASDAQ Disclaimer. View as data table SELLAS Life Sciences Group Inc. SELLAS Life Sciences SLS Prices 463M Shares at 540.

07 2021 GLOBE NEWSWIRE -- SELLAS Life Sciences Group Inc. On average they anticipate SELLAS Life Sciences Groups share price to reach 1725 in the next year. Their forecasts range from 1400 to 2100.

102 rows SELLAS Life Sciences Group Inc. In terms of relative price strength the Sellas Life Sciences share price has underperformed the SP500 Index by -6564 over the past year. SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc. This suggests a possible upside of 6533 from the stocks current price. Learn about SELLAS Life Sciences Group Inc SLSXNAS stock quote with Morningstars rating and analysis and stay up to date with the current news price valuation dividends and other stock.

SLS SELLAS or the Company a late-stage clinical biopharmaceutical company focused on the.


Sellas Life Sciences Sls Market Capitalization


Sellas Life Sciences Group Nasdaq Sls Adds Us 28m To Market Cap In The Past 7 Days Though Investors From Three Years Ago Are Still Down 88


Sellas Life Sciences Stock Plunges After 25m Capital Raise Via Equity In Licenses Cancer Focused Cdk9 Inhibitor


Investors Stock Information Sellas Life Sciences


Sellas Life Sciences Group Nasdaqcm Sls Share Price News Analysis Simply Wall St


Should You Buy Sellas Life Sciences Stock After The Fall Today


Sellas Life Sciences Group Inc Sls Stock 10 Year History


Sellas Life Sciences Aktienkurs Aktien A2pu3t Us81642t2096 Borsenkurs


Sls Stock Price And Chart Nasdaq Sls Tradingview


Sellas Life Sciences Announces Pricing Of 25 0 Million Underwritten Public Offering


Sls Institutional Ownership Sellas Life Sciences Group Inc Nasdaq Stock


Sellas Life Sciences Group Inc Sls Stock 10 Year History


Is Sellas Life Sciences Group Nasdaq Sls In A Good Position To Invest In Growth Simply Wall St News


Sellas Life Sciences Group Inc Sls Stock 10 Year History


Sellas Life Sciences Group Inc Stock 2 782


Sls Stock Price And Chart Nasdaq Sls Tradingview


Sls Stock Price And Chart Nasdaq Sls Tradingview


Earnings Whisper Number For Sls Sellas Life Sciences Group


Sellas Life Sciences Group Inc Sls Stock 10 Year History

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel